NEMA AYADPOOR: Open Payments
NPI 1205228350 · OKLAHOMA CITY, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,195 in 32 payments from 7 companies in 2025. Trend: 2023 $1,619 · 2024 $1,297 · 2025 $1,195
Food & beverage: $1,195
| Company | Payments | Amount |
|---|---|---|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 12 | $499 |
| Novo Nordisk Inc | 8 | $355 |
| E.R. Squibb & Sons, L.L.C. | 2 | $136 |
| Abbott Laboratories | 6 | $130 |
| Novartis Pharmaceuticals Corporation | 2 | $39 |
| PFIZER INC. | 1 | $19 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $16 |
Products named: LifeVest, Ozempic, Wegovy, AVEIR, LEQVIO, CONFIRM RX, VYNDAQEL, JARDIANCE.
Industry payments across OK — which companies pay providers there.
